CH598257A5 - - Google Patents
Info
- Publication number
- CH598257A5 CH598257A5 CH665074A CH665074A CH598257A5 CH 598257 A5 CH598257 A5 CH 598257A5 CH 665074 A CH665074 A CH 665074A CH 665074 A CH665074 A CH 665074A CH 598257 A5 CH598257 A5 CH 598257A5
- Authority
- CH
- Switzerland
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US367498A US3878206A (en) | 1973-06-06 | 1973-06-06 | 9-(Substituted amino)imidazo{8 4,5-f{9 quinolines |
Publications (1)
Publication Number | Publication Date |
---|---|
CH598257A5 true CH598257A5 (fr) | 1978-04-28 |
Family
ID=23447415
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH665074A CH598257A5 (fr) | 1973-06-06 | 1974-05-15 |
Country Status (13)
Country | Link |
---|---|
US (1) | US3878206A (fr) |
JP (1) | JPS5738593B2 (fr) |
AU (1) | AU473160B2 (fr) |
BE (1) | BE816004A (fr) |
CH (1) | CH598257A5 (fr) |
DE (1) | DE2427410A1 (fr) |
DK (1) | DK133104C (fr) |
FR (1) | FR2232318B1 (fr) |
GB (1) | GB1402243A (fr) |
IL (1) | IL44166A (fr) |
NL (1) | NL7406572A (fr) |
SE (1) | SE391926B (fr) |
ZA (1) | ZA74798B (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GR65025B (en) * | 1977-07-21 | 1980-06-16 | Thomae Gmbh Dr K | Method for the preparation of new imidazo-isokinolin-diones |
ATE18354T1 (de) * | 1981-12-14 | 1986-03-15 | Norwich Eaton Pharma | Verwendung von 9-(p-(n-methylacetamido)anilino)7methyl-1h-imidazo(4,5-f)chinolin als anti-tumor mittel. |
JPS58162592U (ja) * | 1982-04-24 | 1983-10-29 | 音羽電機工業株式会社 | 避雷器の切離し装置 |
JPS6017589U (ja) * | 1983-07-15 | 1985-02-06 | 三菱電機株式会社 | 避雷器の自動切離し装置 |
EP0187705A3 (fr) * | 1985-01-08 | 1988-05-11 | Norwich Eaton Pharmaceuticals, Inc. | Imidazo(4,5-f)quinolines utiles comme agents immunomodulateurs |
US4716168A (en) * | 1985-01-08 | 1987-12-29 | Norwich Eaton Pharmaceuticals, Inc. | Imidazo(4,5-f)quinolines useful as immunomodulating agents |
AU2002227202A1 (en) * | 2000-12-05 | 2002-06-18 | Quest Medicine, Inc. | The use of polymers for inactivating pathogens |
KR100453946B1 (ko) * | 2002-10-11 | 2004-10-20 | (주) 비엔씨바이오팜 | 6-메틸피리딘 유도체, 그 제조방법 및 이를 포함하는 항바이러스용 약학적 조성물 |
CA2508618C (fr) * | 2002-12-06 | 2012-02-21 | Bayer Healthcare Ag | Derives de tetrahydro-naphthalene |
US7544716B2 (en) | 2002-12-09 | 2009-06-09 | Xention Limited | Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists |
GB0516564D0 (en) * | 2005-08-12 | 2005-09-21 | Ge Healthcare Ltd | Fluorination process |
-
1973
- 1973-06-06 US US367498A patent/US3878206A/en not_active Expired - Lifetime
-
1974
- 1974-02-06 ZA ZA00740798A patent/ZA74798B/xx unknown
- 1974-02-07 IL IL44166A patent/IL44166A/en unknown
- 1974-02-11 AU AU65452/74A patent/AU473160B2/en not_active Expired
- 1974-02-26 GB GB871774A patent/GB1402243A/en not_active Expired
- 1974-04-26 SE SE7405653A patent/SE391926B/xx unknown
- 1974-05-15 CH CH665074A patent/CH598257A5/xx not_active IP Right Cessation
- 1974-05-16 NL NL7406572A patent/NL7406572A/xx not_active Application Discontinuation
- 1974-05-27 JP JP5887974A patent/JPS5738593B2/ja not_active Expired
- 1974-06-05 FR FR7419424A patent/FR2232318B1/fr not_active Expired
- 1974-06-06 DK DK302074A patent/DK133104C/da active
- 1974-06-06 BE BE145153A patent/BE816004A/fr unknown
- 1974-06-06 DE DE19742427410 patent/DE2427410A1/de active Pending
Also Published As
Publication number | Publication date |
---|---|
DK302074A (fr) | 1975-02-03 |
AU6545274A (en) | 1975-08-14 |
GB1402243A (en) | 1975-08-06 |
JPS5019775A (fr) | 1975-03-01 |
DE2427410A1 (de) | 1975-01-09 |
DK133104B (da) | 1976-03-22 |
FR2232318A1 (fr) | 1975-01-03 |
SE7405653L (fr) | 1974-12-09 |
NL7406572A (fr) | 1974-12-10 |
FR2232318B1 (fr) | 1977-07-08 |
IL44166A0 (en) | 1974-05-16 |
IL44166A (en) | 1976-08-31 |
SE391926B (sv) | 1977-03-07 |
AU473160B2 (en) | 1976-06-17 |
US3878206A (en) | 1975-04-15 |
DK133104C (da) | 1976-08-23 |
BE816004A (fr) | 1974-12-06 |
JPS5738593B2 (fr) | 1982-08-16 |
ZA74798B (en) | 1975-09-24 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |